Everyday functioning as a predictor of cognitive status in a group of community-dwelling, predominantly Black adults.

Introduction: We examined whether the Performance Assessment of Self-Care Skills (PASS) and Everyday Cognition Scale-12 (ECog-12) dichotomized cognitive groups in a sample of predominantly Black adults.

Methods: Two hundred forty-six community-dwelling adults (95% Black, age 50+) completed cognitive testing, the PASS, and the ECog. Cognitive groups (probable vs unlikely cognitive impairment) were determined by performance on the Modified Mini-Mental State Examination.

Disentangling the genetic underpinnings of neuropsychiatric symptoms in Alzheimer's disease in the Alzheimer's Disease Sequencing Project: Study design and methodology.

Introduction: Neuropsychiatric symptoms (NPS) are highly prevalent in Alzheimer's disease (AD). There are no effective treatments targeting these symptoms.

Methods: To facilitate identification of causative mechanistic pathways, we initiated an effort (NIH: U01AG079850) to collate, harmonize, and analyze all available NPS data (≈ 100,000 samples) of diverse ancestries with whole-genome sequencing data from the Alzheimer's Disease Sequencing Project (ADSP).

Discriminative accuracy of the A/T/N scheme to identify cognitive impairment due to Alzheimer's disease.

Introduction: The optimal combination of amyloid-β/tau/neurodegeneration (A/T/N) biomarker profiles for the diagnosis of Alzheimer's disease (AD) dementia is unclear.

Methods: We examined the discriminative accuracy of A/T/N combinations assessed with neuroimaging biomarkers for the differentiation of AD from cognitively unimpaired (CU) elderly and non-AD neurodegenerative diseases in the TRIAD, BioFINDER-1 and BioFINDER-2 cohorts (total  = 832) using area under the receiver operating characteristic curves (AUC).

Results: For the diagnosis of AD dementia (vs.